This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

• UBS analyst Leonardo Olmos downgraded the rating for Globant S.A. GLOB from Buy to Neutral, while raised the price target from $225 to $235. Globant shares fell 1.1% to close at $201.98 on Monday. See how other analysts view this stock.
• Citigroup analyst Thomas Singlehurst downgraded Stride, Inc. LRN from Buy to Neutral, but increased the price target from $77 to $90. Stride shares gained 1.5% to close at $83.77 on Monday. See how other analysts view this stock.
• JP Morgan analyst Tien-Tsin Huang downgraded the rating for AvidXchange Holdings, Inc. AVDX from Overweight to Neutral and lowered the price target from $11 to $9. AvidXchange shares gained 1.4% to close at $8.24 on Monday. See how other analysts view this stock.
• JMP Securities analyst Nicholas Jones downgraded PropertyGuru Group Limited PGRU from Market Outperform to Market Perform. PropertyGuru shares settled at $6.55 on Monday. See how other analysts view this stock.
• Benchmark analyst Robert Wasserman downgraded the rating for AbCellera Biologics Inc. ABCL from Buy to Hold. AbCellera Biologics shares gained 3.8% to close at $2.71 on Monday. See how other analysts view this stock. See how other analysts view this stock.

Considering buying GLOB stock? Here’s what analysts think:

Read Next:

• S&P 500, Nasdaq Extend Gains For 8th Consecutive Session: Investor Sentiment Improves, But Greed Index Remains In ‘Fear’ Zone